More articles from Outcomes/Comparative Effectiveness Research

You have access
A new complex diagnostic protocol for the diagnosis of nasolacrimal duct obstruction: Simultaneous dacryocystography and dacryoscintigraphy using SPECT/CT
Lajos Szabados, Sandor Barna, Adam Kemeny-Beke, Beata Kettesy, Jozsef Varga, Laszló Galuska, Andras Berta and Ildiko Garai

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 475;
You have access
A systematic literature review of clinical comparative effectiveness and cost-effectiveness evidence for PET in oncology
Brian Bresnahan, Cara McDermott, Veena Shankaran and David Mankoff

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 479;
You have access
Is FDG PET/CT cost-effective for pre-operation staging of potentially operative non-small cell lung cancer? From Chinese healthcare system perspective
Yuting Wang and Gang Huang

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 480;
You have access
Comparison of PET vs MRI for evaluation of treated high grade primary brain tumors
Yamil Fourzali and Lance Hall

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 478;
You have access
SPECT-CT in routine clinical use: Increment in patient radiation dose compared to SPECT alone
Shekhar Sharma, Punit Sharma, Rama Reddy, Sanjana Ballal, Rakesh Kumar, Chandrasekhar Bal and Arun Malhotra

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 477;
You have access
Feasibility of low-dose FDG for whole-body TOF PET/CT oncologic workup
Adam Alessio, Hubert Vesselle, David Lewis, Manuela Matesan, Fatemeh Behnia, Julianne Suhy, Bart de Boer, Piotr Maniawski and Satoshi Minoshima

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 476;
You have access
A cost-efficient diagnostic imaging algorithm incorporating I-123 MIBG SPECT/CT for suspected pheochromocytoma
Michael Stamm and Jonathan Abele

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 474;
You have access
Cost-effectiveness of FDG-PET/CT in patients with Gram[+] bacteraemia
Fidel Vos, Chantal Bleeker-Rovers, Bart-Jan Kullberg, Eddy Adang and Wim Oyen

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 67;
You have access
Ga-68 DOTATOC PET/CT and In-111-DTPA-Octreotide SPECT for staging of enteropancreatic neuroendocrine tumors: Evaluation of costs and consequential costs
Nils Schreiter, Bernd Hamm, Munenobu Nogami, Ulrich-Frank Pape, Ralph Buchert, Winfried Brenner and Martin Maurer

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 70;
You have access
The incidence of clinically important PET-negative CT-positive findings in a large clinical PET/CT practice
Tanche Wang, Jonathan Abele and Johnny Li

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 69;

Main menu

User menu

Search

More articles from Outcomes/Comparative Effectiveness Research

Pages